GlassScriptPhysician profile
Howard R Sussman
NPI 1497799571
$5,633.16
in general payments reported to CMS, 2019-2025
20 companies · $861 in 2025
The $861 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $304 · 2021: $861 · 2022: $1,000 · 2023: $1,134 · 2024: $955 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,949.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $762.12 | 2019-2024 | Mounjaro, Jardiance |
| Esperion Therapeutics, INC. | $724.02 | 2021-2023 | Nexletol, Nexlizet |
| Mannkind Corporation | $702.98 | 2020-2024 | Afrezza |
| Insulet Corporation | $677.66 | 2023-2025 | Omnipod |
| Intuity Medical INC | $520.40 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ascensia Diabetes Care US INC. | $293.13 | 2023 | |
| Xeris Pharmaceuticals, INC. | $259.86 | 2024 | Recorlev |
| Dexcom, INC. | $257.33 | 2023-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.96 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $231.38 | 2019 | |
| Beta Bionics, INC. | $181.62 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Amgen INC. | $145.90 | 2024-2025 | Evenity |
| Abbott Laboratories | $135.00 | 2024 | Freestyle Libre 3 |
| Nevro Corp. | $120.33 | 2022 | |
| Novo Nordisk INC | $106.24 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $100.00 | 2025 | Yorvipath |
| Tandem Diabetes Care, INC. | $99.31 | 2020 | |
| Abbvie INC. | $34.50 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.41 | 2024 | |
| Hologic Sales and Service, LLC | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Sussman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.